Read our November 2017 issue.

Our November issue covers CNS disorders, gene therapy and pharmaceutical deal preparation.

Like Comment

Read our November 2017 edition here.

Our last issue of the year includes a host of company profiles actively seeking partners and three features that cover dealmaking trends within CNS disorders, a timeline of gene therapy events and information regarding how to prepare for a pharmaceutical deal. 

November features 

  • Partnering for CNS disorders 
  • Taking a journey through gene therapy
  • How to prepare for a pharmaceutical deal
Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.